Trial intelligence / Profile preview

SIDAMI: Sildenafil for Diastolic Dysfunction After AMI

NCT01046838Phase 4Completed

Start
Dec 2009
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ASP-001 in heart failure with preserved ejection fraction (HFpEF). Started Dec 2009; status: completed.

02

Drugs

ASP-001
03

Conditions

heart failure with preserved ejection fraction (HFpEF)

Beyond the preview

Go deeper on NCT01046838.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01046838.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call